Prof John Radford

Chair in Teenage & Young Adult Cancer

Full contact details
View graph of relations


  1. 2022
  2. Published

    Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity

    Henriksen, P. A., Hall, P., Oikonomidou, O., Macpherson, I. R., Maclean, M., Lewis, S., McVicars, H., Broom, A., Scott, F., McKay, P., Borley, A., Rowntree, C., Lord, S., Collins, G., Radford, J., Guppy, A., Payne, J. R., Newby, D. E., Mills, N. L. & Lang, N. N., 1 Jul 2022, In: Circulation: Heart Failure. 15, 7, p. E009445

    Research output: Contribution to journalReview articlepeer-review

  3. E-pub ahead of print

    Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma

    Ghione, P., Palomba, M. L., Patel, A., Bobillo, S., Deighton, K., Jacobson, C. A., Nahas, M., Hatswell, A. J., Jung, A. S., Kanters, S., Snider, J. T., Neelapu, S. S., Ribeiro, M. T., Brookhart, M. A., Ghesquieres, H., Radford, J. & Gribben, J. G., 9 Jun 2022, (E-pub ahead of print) In: Blood.

    Research output: Contribution to journalArticlepeer-review

  4. Published

    Likely uptake of a future a lung cancer screening programme in Hodgkin lymphoma survivors: a questionnaire study

    Broadbent, R., Armitage, C. J., Crosbie, P., Radford, J. & Linton, K., 28 Apr 2022, In: BMC Pulmonary Medicine. 22, 1, p. 165 165.

    Research output: Contribution to journalArticlepeer-review

  5. 2021
  6. Published

    Breast Dose in Young Women Treated for Hodgkin Lymphoma Between 2007 and 2018: A Single Institutional Study

    Chamberlin, H. C., Astley, S., Cowan, R., Hague, C., Howell, S. J., Radford, J. A., Tenant, S., Williams, J. L. R. & Aznar, M. C., 1 Nov 2021, In: International journal of radiation oncology, biology, physics. 111, 3, p. e304-e305

    Research output: Contribution to journalArticlepeer-review

  7. Published

    Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study

    Hawkes, E. A., Phillips, T., Budde, L. E., Santoro, A., Saba, N. S., Roncolato, F., Gregory, G. P., Verhoef, G., Offner, F., Quero, C., Radford, J., Giannopoulos, K., Stevens, D., Thall, A., Huang, B., Laird, A. D., Sandner, R. & Ansell, S. M., 23 Oct 2021, In: Targeted Oncology.

    Research output: Contribution to journalArticlepeer-review

  8. Published

    Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

    Kim, W. S., Oki, Y., Kim, S. J., Yoon, S. E., Ardeshna, K. M., Lin, Y., Ruan, J., Porcu, P., Brammer, J. E., Jacobsen, E. D., Yoon, D. H., Suh, C., Suarez, F., Radford, J., Budde, L. E., Kim, J. S., Bachy, E., Lee, H. J., Bollard, C. M., Jaccard, A. & 9 others, Kang, H. J., Inman, S., Murray, M., Combs, K. E., Lee, D. Y., Advani, R., Gunter, K. C., Rooney, C. M. & Heslop, H. E., 1 Oct 2021, In: Annals of Hematology. 100, 10, p. 2529-2539 11 p.

    Research output: Contribution to journalArticlepeer-review

  9. Published

    Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Spira, A., Zhou, X., Chen, L., Gnanasakthy, A., Wang, L., Ungar, D., Curiel, R., Liao, L., Radford, J. & Kahl, B., 22 Sep 2021, In: Clinical Lymphoma, Myeloma and Leukemia.

    Research output: Contribution to journalArticlepeer-review

  10. Published

    Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial

    Herrera, A. F., Burton, C., Radford, J., Miall, F., Townsend, W., Santoro, A., Zinzani, P. L., Lewis, D., Fowst, C., Brar, S., Huang, B., Thall, A. & Collins, G. P., 14 Sep 2021, In: Blood Advances. 5, 17, p. 3387-3396 10 p.

    Research output: Contribution to journalArticlepeer-review

  11. Published

    Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma

    Cutter, D. J., Ramroth, J., Diez, P., Buckle, A., Ntentas, G., Popova, B., Clifton-Hadley, L., Hoskin, P. J., Darby, S. C., Radford, J. & Illidge, T., 13 Aug 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. JCO.21.00408.

    Research output: Contribution to journalArticlepeer-review

  12. Published

    Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

    Evens, A. M., Connors, J. M., Younes, A., Ansell, S. M., Kim, W. S., Radford, J., Feldman, T., Tuscano, J., Savage, K. J., Oki, Y., Grigg, A., Pocock, C., Dlugosz-Danecka, M., Fenton, K., Forero-Torres, A., Liu, R., Jolin, H., Gautam, A. & Gallamini, A., 24 Jun 2021, In: Haematologica.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 6 7 8 ...37 Next